List of Suprenza drug patents

Suprenza is owned by Citius Pharms.

Suprenza contains Phentermine Hydrochloride.

Suprenza has a total of 1 drug patent out of which 0 drug patents have expired.

Suprenza was authorised for market use on 13 June, 2011.

Suprenza is available in tablet, orally disintegrating;oral dosage forms.

The generics of Suprenza are possible to be released after 14 March, 2029.

SUPRENZA Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8440170 CITIUS PHARMS Orally disintegrating tablets with speckled appearance
Mar, 2029

(5 years from now)

Drugs and Companies using PHENTERMINE HYDROCHLORIDE ingredient

Market Authorisation Date: 13 June, 2011

Treatment: NA


How can I launch a generic of SUPRENZA before it's patent expiration?
More Information on Dosage

SUPRENZA family patents


United States


European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic